Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excimer Lamp + Tacrolimus for Pediatric Vitiligo
NCT06035614Completed
- Sponsor
- Clarteis
- Start
- Oct 2022
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Clarteis. Primary endpoint: Repigmentation rate at 4 months. Started Oct 2022; status: completed.
Beyond the preview
Go deeper on NCT06035614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06035614.